[HTML][HTML] A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
Abstract Background/Objectives: Obesity is a risk factor for COVID-19 infection severity and
mortality. Anti-obesity medications (AOM) are effective for weight loss. However, weight loss
outcomes with AOM during the COVID-19 pandemic are yet to be described.
Subjects/Methods: Between January 1, 2016, and June 30, 2021, a total of 966 patients
were prescribed long-term FDA-approved AOMs at the Mayo Clinic. From these patients,
711 patients did not meet inclusion criteria. A total of 255 patients were included …
mortality. Anti-obesity medications (AOM) are effective for weight loss. However, weight loss
outcomes with AOM during the COVID-19 pandemic are yet to be described.
Subjects/Methods: Between January 1, 2016, and June 30, 2021, a total of 966 patients
were prescribed long-term FDA-approved AOMs at the Mayo Clinic. From these patients,
711 patients did not meet inclusion criteria. A total of 255 patients were included …
以上显示的是最相近的搜索结果。 查看全部搜索结果